Loading...
Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases
Basal cell carcinoma (BCC) is the most common periocular skin cancer and can lead to significant morbidity. We assess the effectiveness of vismodegib, a first-in-class Hedgehog signaling pathway inhibitor, in the management of periocular and orbital BCCs based on clinical response, tolerability, and...
Na minha lista:
| Udgivet i: | Plast Reconstr Surg Glob Open |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548583/ https://ncbi.nlm.nih.gov/pubmed/28831360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GOX.0000000000001424 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|